Patent · US Expired

Compositions of optically pure (+) norcisapride

US6632827B2 · kind B2 · utility

14Cited by
6References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 16, 2001
Grant dateOct 14, 2003
Priority date—
Expiry dateMar 16, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods utilizing the optically pure (+) isomer of norcisapride are disclosed. This compound has surprisingly been found to be a potent drug for the treatment of disorders of the central nervous system. The compound, (+) norcisapride, has also been found to be a potent antiemetic agent. Finally, the (+) isomer of norcisapride also avoids certain adverse side effects and certain adverse drug interactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.